Al sinds het prille begin van de coronacrisis zijn meerdere reviews verschenen over het potentieel van melatonine tegen COVID-19. Als u denkt: 'melatonine, het slaaphormoon?', dan is het hoog tijd om dat beeld bij te stellen. Melatonine is op de eerste plaats een antioxidant, maar eentje met vele bijrollen die ook betrekking hebben op antivirale bescherming en ontsteking.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Verschenen in
Referenties
Tan DX, Reiter RJ. Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res. 2019 Feb; 2(1): 44-66.
Ramos E, López-Muñoz F, Gil-Martín E, et al. The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy. Antioxidants (Basel). 2021 Jul 20;10(7):1152.
Shneider A, Kudriavtsev A, Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020;39(4):153-162.
Feitosa EL, Júnior FTDSS, Nery Neto JAO, et al. COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor. Int J Med Sci. 2020 Jul 30;17(14):2133-2146.
Su H, Li J, Chen Tet, et al. Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA/CD147 signaling pathway. Mol Cell Biochem. 2016 Nov;422(1-2):85-95.
Zarezadeh M, Khorshidi M, Emami M, et al. Melatonin supplementation and pro-inflammatory mediators: a systematic review and meta-analysis of clinical trials. Eur J Nutr. 2020 Aug;59(5):1803-1813.
Zhang Y, Li X, Grailer JJ, et al. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome. J Pineal Res. 2016 May;60(4):405-14.
Calvo JR, González-Yanes C, Maldonado MD. The role of melatonin in the cells of the innate immunity: a review. J Pineal Res. 2013 Sep;55(2):103-20.
Markus RP, Fernandes PA, Kinker GS, et al. Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br J Pharmacol. 2018 Aug;175(16):3239-3250.
Camp OG, Bai D, Gonullu DC, et al. Melatonin interferes with COVID-19 at several distinct ROS-related steps. J Inorg Biochem. 2021 Oct;223:111546.
Mousavi R, Alizadeh M, Asghari Jafarabadi M, et al. Effects of Melatonin and/or Magnesium Supplementation on Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2021 May 19.
Ostadmohammadi V, Soleimani A, Bahmani F, et al. The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. J Ren Nutr. 2020 May;30(3):242-250.
Nabatian-Asl M, Ghorbanihaghjo A, Malek Mahdavi A, et al. Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: A randomised, double-blind, placebo-controlled trial. Int J Clin Pract. 2021 Jul;75(7):e14246.
Esalatmanesh K, Loghman A, Esalatmanesh R, et al. Effects of melatonin supplementation on disease activity, oxidative stress, inflammatory, and metabolic parameters in patients with rheumatoid arthritis: a randomized double-blind placebo-controlled trial. Clin Rheumatol. 2021 Sep;40(9):3591-3597.
Cheikh M, Makhlouf K, Ghattassi K, et al. Melatonin ingestion after exhaustive late-evening exercise attenuate muscle damage, oxidative stress, and inflammation during intense short term effort in the following day in teenage athletes. Chronobiol Int. 2020 Feb;37(2):236-247.
Sánchez-López AL, Ortiz GG, Pacheco-Moises FP, et al. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis. Arch Med Res. 2018 Aug;49(6):391-398.
Raygan F, Ostadmohammadi V, Bahmani F, et al. Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Clin Nutr. 2019 Feb;38(1):191-196.
de Matos Cavalcante AG, de Bruin PF, de Bruin VM, et al. Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study. J Pineal Res. 2012 Oct;53(3):238-44.
Mistraletti G, Paroni R, Umbrello M, et al. Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients. Int J Mol Sci. 2017 Apr 3;18(4):759.
Corona G, Pizzocaro A, Vena W, et al. Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis. Rev Endocr Metab Disord. 2021 Jun;22(2):275-296.
Shabani A, Foroozanfard F, Kavossian E, et al. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. J Affect Disord. 2019 May 1;250:51-56.
Bahrami M, Cheraghpour M, Jafarirad S, et al. The role of melatonin supplement in metabolic syndrome: A randomized double blind clinical trial,Nutr Food Sci. 2019; 49(5): 965-977.
Cagnacci A, Arangino S, Renzi A, et al. Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women. Clin Endocrinol (Oxf). 2001 Mar;54(3):339-46.
Kampmann U, Lauritzen ES, Grarup N, et al. Acute metabolic effects of melatonin-A randomized crossover study in healthy young men. J Pineal Res. 2021 Mar;70(2):e12706.
Brown GM, Pandi-Perumal SR, Pupko H, et al. Melatonin as an Add-On Treatment of COVID-19 Infection: Current Status. Diseases. 2021 Sep 20;9(3):64.
Mousavi SA, Heydari K, Mehravaran H, et al. Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, randomized, controlled trial. J Med Virol. 2022 Jan;94(1):263-271.
Schulte W, Bernhagen J, Bucala R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view. Mediators Inflamm. 2013;2013:165974.
Liu G, Jiang C, Lin X, et al. Point-of-care detection of cytokines in cytokine storm management and beyond: Significance and challenges. View (Beijing). 2021 May 4:20210003.
Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001 Dec;50(6):756-60.
Henderson R, Kim S, Lee E. Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis. Complement Ther Med. 2018 Aug;39:131-136.
Ramlall V, Zucker J, Tatonetti N. Melatonin is significantly associated with survival of intubated COVID-19 patients. medRxiv [Preprint]. 2020 Oct 18:2020.10.15.20213546.
Sánchez-González MÁ, Mahíllo-Fernández I, Villar-Álvarez F, et al. What if melatonin could help COVID-19 severe patients? J Clin Sleep Med. 2021 Jul 20.
Castillo RR, Quizon GRA, Juco MJM, et al. Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO): a case series. Melatonin Res. 2020 Jun; 3(3):297-310.
Farnoosh G, Akbariqomi M, Badri T, et al. Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial. Arch Med Res. 2021 Jun 23:S0188-4409(21)00141-7.
Hosseini A, Esmaeili Gouvarchin Ghaleh H, Aghamollaei H, et al. Evaluation of Th1 and Th2 mediated cellular and humoral immunity in patients with COVID-19 following the use of melatonin as an adjunctive treatment. Eur J Pharmacol. 2021 Aug 5;904:174193.
Hasan ZT, Atrakji DMQYMAA, Mehuaiden DAK. The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients. Int J Infect Dis. 2021 Oct 12;114:79-84.
